C

Chabiotech Co Ltd
KOSDAQ:085660

Watchlist Manager
Chabiotech Co Ltd
KOSDAQ:085660
Watchlist
Price: 14 860 KRW -2.49%
Market Cap: 836.8B KRW
Have any thoughts about
Chabiotech Co Ltd?
Write Note
Chabiotech Co Ltd
/
Income Statement
/
Cost of Revenue

Chabiotech Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chabiotech Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Chabiotech Co Ltd
KOSDAQ:085660
Cost of Revenue
-₩743.7B
CAGR 3-Years
-14%
CAGR 5-Years
-17%
CAGR 10-Years
-11%
No Stocks Found

Chabiotech Co Ltd
Glance View

Market Cap
836.8B KRW
Industry
Health Care

Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-27. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.

Intrinsic Value
9 965.82 KRW
Overvaluation 33%
Intrinsic Value
Price
C
What is Intrinsic Value?

See Also

What is Chabiotech Co Ltd's Cost of Revenue?
Cost of Revenue
-743.7B KRW

Based on the financial report for Sep 30, 2024, Chabiotech Co Ltd's Cost of Revenue amounts to -743.7B KRW.

What is Chabiotech Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-11%

Over the last year, the Cost of Revenue growth was 11%. The average annual Cost of Revenue growth rates for Chabiotech Co Ltd have been -14% over the past three years , -17% over the past five years , and -11% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.